











































Application across species of a one health approach to liquid
sample handling for respiratory based -omics analysis
Citation for published version:
Karagianni, A, Eaton, S, Thekkedath Kurian, D, Cillan-Garcia, E, Twynam-Perkins, J, Raper, A, Wishart, T &
Pirie, S 2021, 'Application across species of a one health approach to liquid sample handling for respiratory
based -omics analysis', Scientific Reports, vol. 11, no. 1, 14292. https://doi.org/10.1038/s41598-021-93839-
9
Digital Object Identifier (DOI):
10.1038/s41598-021-93839-9
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 23. Jul. 2021
1
Vol.:(0123456789)
Scientific Reports |        (2021) 11:14292  | https://doi.org/10.1038/s41598-021-93839-9
www.nature.com/scientificreports
Application across species of a one 
health approach to liquid sample 
handling for respiratory based 
‑omics analysis
Anna E. Karagianni1*, Samantha L. Eaton1, Dominic Kurian1, Eugenio Cillán‑Garcia1, 
Jonathan Twynam‑Perkins2, Anna Raper1, Thomas M. Wishart1,3 & R. Scott Pirie1,3
Airway inflammation is highly prevalent in horses, with the majority of non‑infectious cases being 
defined as equine asthma. Currently, cytological analysis of airway derived samples is the principal 
method of assessing lower airway inflammation. Samples can be obtained by tracheal wash (TW) or 
by lavage of the lower respiratory tract (bronchoalveolar lavage (BAL) fluid; BALF). Although BALF 
cytology carries significant diagnostic advantages over TW cytology for the diagnosis of equine 
asthma, sample acquisition is invasive, making it prohibitive for routine and sequential screening 
of airway health. However, recent technological advances in sample collection and processing have 
made it possible to determine whether a wider range of analyses might be applied to TW samples. 
Considering that TW samples are relatively simple to collect, minimally invasive and readily available 
in the horse, it was considered appropriate to investigate whether, equine tracheal secretions 
represent a rich source of cells and both transcriptomic and proteomic data. Similar approaches 
have already been applied to a comparable sample set in humans; namely, induced sputum. Sputum 
represents a readily available source of airway biofluids enriched in proteins, changes in the expression 
of which may reveal novel mechanisms in the pathogenesis of respiratory diseases, such as asthma 
and chronic obstructive pulmonary disease. The aim of this study was to establish a robust protocol to 
isolate macrophages, protein and RNA for molecular characterization of TW samples and demonstrate 
the applicability of sample handling to rodent and human pediatric bronchoalveolar lavage fluid 
isolates. TW samples provided a good quality and yield of both RNA and protein for downstream 
transcriptomic/proteomic analyses. The sample handling methodologies were successfully applicable 
to BALF for rodent and human research. TW samples represent a rich source of airway cells, and 
molecular analysis to facilitate and study airway inflammation, based on both transcriptomic and 
proteomic analysis. This study provides a necessary methodological platform for future transcriptomic 
and/or proteomic studies on equine lower respiratory tract secretions and BALF samples from humans 
and mice.
The European Thoroughbred horseracing sector has an annual economic impact of €12 billion, including approxi-
mately 155,000 employees in a variety of roles (British Horseracing Authority). Racehorses commonly develop 
airway inflammation and/or exercise induced pulmonary haemorrhage during training, with prevalence rates 
as high as 70–80% and 100% respectively, resulting in a significant impact on animal welfare and the racehorse 
 industry1–3. Cytological analysis of tracheal wash (TW) and bronchoalveolar lavage fluid (BALF) is the most 
commonly applied method of assessing lower respiratory tract health of the horse and helps to guide  therapy4,5. 
The diagnostic application of this technique includes the identification of common equine airway disorders of 
the horse, including equine asthma and exercise induced pulmonary  haemorrhage6,7. Tracheal wash, BALF, 
peritoneal fluid and blood samples are commonly obtained by equine veterinarians and analysed for diagnostic 
 purposes8–11. Despite that, a limited number of equine airway derived gene expression studies have been reported 
in the literature, largely aimed at defining the pathogenesis of equine  asthma12–14. In each of these studies, the 
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airway cells were derived from BALF samples, which are more difficult to obtain due to the invasive collection 
procedure. In comparison, the analyses of TW samples rarely extend beyond cytology and subjective scoring of 
mucus content. However, recent technological advances in sample collection and processing procedures have 
made it possible to determine whether a wider range of analyses might be applied to TW samples. This would 
be advantageous as equine tracheal secretions represent a rich source of: (i) cells, (ii) host-derived microbiome, 
(iii) transcriptome and (iv) local environment-derived proteins; and (v) are relatively simple to collect with 
minimal discomfort to the horse.
Similar approaches have already been applied to a comparable sample set in  humans15,16; namely, induced 
sputum. Induced sputum in humans provides a non-invasive method to sample airway biofluids that are enriched 
in proteins and may reveal novel mechanisms in the pathogenesis of respiratory diseases, such as asthma and 
chronic obstructive pulmonary  disease16,17. For equine derived samples, the proteomic approach is novel and 
follows a recent upsurge of interest in proteomic analysis of human airway secretions as a highly informative non-
invasive method of assessing the mechanisms associated with lung  disease15. Application of both a transcriptomic 
and proteomic approach to equine TW samples has the potential to reveal novel biomarkers of early disease 
development or disease associated tissue remodelling. Furthermore, such investigations could provide additional 
criteria on which to base disease subcategorization (e.g., equine asthma) and/or identify novel therapeutic targets.
In keeping with the One-Health-concept, the horse is widely acknowledged as an attractive model for human 
 asthma3,18,19, addressing needs that cannot be addressed through small animal models: mice are widely recognised 
as poor models of the human immune response, particularly in relation to the  lung20,21. In addition to the impor-
tant similarities between horses and humans with regard to both pathophysiology and macrophage/monocyte 
biology, the horse also represents an ideal source of large volumes of various biological sample  types18,19,22–25. 
For example, the volume and the associated cell retrieval rates derived from horses represent at least 2–3 orders 
of magnitude greater than those obtained from rodent models. This is of particular relevance in light of the 
extremely limited availability of human derived samples.
Thus, in this study we investigated the most appropriate means of (a) isolating airway macrophages from 
TW and (b) maximising the yield and quality of RNA and protein from equine TW samples. Furthermore, we 
compared the relevance of our results to murine and paediatric samples, determining whether a similar approach 
might be adopted.
Results
The aim of this project was to highlight the usefulness of TW samples for several biological applications (Fig. 1) 
and to establish the conditions for optimal RNA and protein isolation, in order to use for transcriptomic and 
proteomic analysis. Thus, TW samples from 39 Thoroughbred racehorses were collected. Furthermore, the pro-
teomic analysis protocol was successfully applied to equine, murine and human BALF samples.
Establishing a protocol for tracheal wash cell isolation. One aspect of the current project was the 
isolation of macrophages from TW samples. Analysis had confirmed cross-reactivity of an anti-human CD163 
antibody, a classical marker for mature macrophages, and successful application of magnetic bead separation to 
dithiothreitol (DTT)-treated equine tracheal secretion samples. Flow cytometry analysis revealed that almost 
Figure 1.  Multiple clinical and research applications can be investigated with a single tracheal wash sample. 
Endoscopic image is showing the sampling catheter (via the biopsy channel of the endoscope) within a “pool” of 
tracheal wash fluid at the level of the thoracic inlet. TW Tracheal wash, DTT dithiothreitol.
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half of the cell population of TW samples were CD163 positive (Fig. 2a–c). Isolation of CD163 positive cells 
was also confirmed with light microscopy on cytospin slide preparations stained with Leishman stain (Fig. 2d).
The present study used a series of 39 horse-derived samples and an average of 5.9 ± 1.7 (± SEM) ×  106 cells 
were isolated from TW samples. RNA average yield extracted from the total cell population of TW samples 
was 244 ± 43 (± SEM)ng/µl. RNA yield concentration of CD163 positive cells was 43 ± 19 (± SEM) ng/µl. RNA 
integrity number (RIN) greater than 7 is recommended for RNAseq and qPCR analysis. RNA samples derived 
from the total population of TW-derived cells had an average RIN number of 7.92 ± 0.14 (± SEM), thus rendering 
samples suitable for sequencing or RNA analysis. Differential cell counts (DCC) of TW samples were as follows 
(mean ± SEM): 38.5 ± 3% macrophages (with no evidence of phagocytosed haemosiderin), 17.8 ± 2.8 macrophages 
with phagocytosed haemosiderin (haemosiderophages), 30.4 ± 1.7% lymphocytes, 13.3 ± 2.4% neutrophils, and 
0.01 ± 0.02 eosinophils. The exclusion of epithelial cells is common practice in both equine and human pulmonol-
ogy, unless they are being selectively harvested mainly for research  purposes26,27. This is mainly due to the large 
variability in their relative proportion to other cell types, depending on factors such as coughing and collection 
technique and the potential to significantly impact the interpretation of inflammatory cell differential counts 
and skew data derived from down-stream  analyses27.
Results of the DCC are shown in Fig. 3. In agreement with the data derived from flow cytometric analysis 
(Fig. 2b) almost half the number of TW cells were macrophages (including haemosiderophages). Since all sam-
ples were collected from racehorses, the presence of haemosiderophages in these samples was unavoidable as 
almost all racing Thoroughbred horses will bleed into the airways; this condition is termed Exercise-Induced 
Pulmonary  Haemorrhage6.
Protein extraction of tracheal wash samples, has been successfully performed. In order to 
expand on the RNA studies, we planned to define the airway protein profiles (total proteome), thus revealing 
the mechanisms which may underpin any alterations in immune function. Protein extraction was successfully 
performed on TW samples from 39 horses. An average of 1.3 ± 0.2 (± SEM) mg protein has been isolated from 
500 µl of TW per animal. Protein extraction of equine BALF samples resulted in 0.8 ± 0.07 (± SEM) mg protein 
isolated from 500 µl. The same protocol was successfully applied on the same volume of human (n = 3) and 
murine (n = 4) BALF samples, from which a protein yield of 0.6 ± 0.1 (± SEM) and 0.4 ± 0.1 (± SEM) mg total 
protein were isolated, respectively.
In order to visualise the total protein load, all samples were run on gradient gels and stained with instant 
blue protein stain. Figure 4 is representative of a gel stain of three equine TW, two BALF samples, as well as two 
Figure 2.  Analysis of tracheal wash derived macrophages. Flow cytometry results showing cross-reactivity 
of mouse anti-human CD163 antibody against equine tracheal macrophages. (a) Isotype control, (b) CD163 
stained cells (c) overlay of CD163+ population on top of total cells. (d) Leishman stained cytospin preparations 
of CD163+ cells by light microscopy (× 20, scale bar = 50 μm). Data and image analysis was performed in  FlowJo® 
v10.5.3 https:// www. flowjo. com/.
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Figure 3.  Differential cell count (mean + SEM %) of equine tracheal wash samples (n = 39). Differential 
leucocyte count (minimum of 200 cells) was performed and expressed as a percentage of total non-squamous 
and non-epithelial nucleated cells.
Figure 4.  Comparison of detectable proteins isolated from equine tracheal wash and bronchoalveolar lavage 
samples of human, mice and horse. Lane 1 shows the protein ladder. Total protein stain of equine (Eq) TW 
samples (Lanes 2–4, 10 ug) and BALF samples (Lanes 5–6, 10 ug). Lanes 7–8 (5 ug) show total protein stain 
from human (Hum) BALF samples and lanes 9–12 (5 ug) contain total protein stain of four murine (Mur) 
BALF samples. Selected prominent bands isolated from the gel and analysed in the Mass Spectometry Facility 
are shown in white boxes (Lane 2, B1–B7). Note the increased diversity of proteins derived from equine TW 
samples compared to BALF. The stained gel was imaged using the LICOR Odyssey imager and the associated 
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human and four murine samples; a number of bands (e.g., B3, B5) showed a similar pattern in each species. 
However, it is important to consider the different protocols applied for sample collection between species, in 
particular if quantitative comparative analysis between species is to be performed. Protein samples were also 
submitted for proteomic analysis.
In order to investigate the variety of proteins present in the samples, selected prominent bands were isolated 
from the gel and analysed in the Mass Spectometry Facility at the Roslin Institute. Uniprot, a comprehensive 
resource for protein sequence and annotation data was used (https:// www. unipr ot. org/ prote omes/ UP000 002281) 
for horse protein annotation.
Initial quality control analysis based on the staining patterns on gel clearly shows protein samples were 
intact and showed no signs of degradation, in spite of the sample preparation and addition of extraction buffer 
components directly into liquid biological samples. Also, a range of protein identities were revealed from a few 
bands analysed by LC–MS (Supplementary Data 1).
Furthermore, in an attempt to investigate whether DTT treatment has an effect on TW derived protein; 
a comparison was also made between DTT treated and untreated TW samples. The addition of DTT during 
sputum processing is widely used to release cells from mucus. However, it is reported that DTT treatment may 
result in decreased detection of inflammatory cytokines in human sputum compared to untreated  samples28. In 
line with this, our results suggested that the yield of unique protein identifications from the untreated samples 
was double that derived from DDT treated samples (Supplementary Data 1). Therefore, we decided to proceed 
with proteomic analysis of TW samples that had not been treated with DTT. In total, 436 unique proteins were 
detected from all samples. Some example proteins detected in the TW samples are shown in Table 1. These are 
related to immune response and lung biology, including CD14, complement factors, immunoglobulins, surfactant 
proteins and mucins, suggesting that samples isolated and processed in this way are likely to be representative 
of the in vivo composition. The complete lists of mapped proteins are presented in the Supplementary Data 1.
KEGG pathway enrichment analysis of the detected proteins was performed using the Database for Annota-
tion, Visualization, and Integrated Discovery (DAVID) annotation software (https:// david. ncifc rf. gov/)29. The 
detected protein list included proteins involved in metabolic pathways and immune response to infection (Sup-
plementary Data 2). Ingenuity Pathway Analysis (IPA) was also used to functionally analyse the list of the 
detected  proteins30. The main canonical pathways and diseases/biofunctions related to the protein list are shown 
in Fig. 5. The IPA-generated network (Fig. 6) contains most of the molecules related to “Cellular Function” and 
“Maintenance”, “Humoral Immune response” and “Inflammatory Response”.
Discussion
To the best of our knowledge, this study has shown for the first time that it is feasible to carry out both transcrip-
tomic and proteomic analysis on a single TW collected from equines, in this case UK national hunt Thorough-
breds. Such samples are routinely collected in veterinary practice, in contrast to the less readily available and 
more technically invasive BAL-derived samples, which have previously been favoured for transcriptomic and 
proteomic  analyses14,31,32. Moreover, macrophages were successfully isolated from TW samples based on mag-
netic bead separation and isolated cells were deemed suitable for downstream transcriptomic analysis. Similar 
experiments have been performed on human isolated macrophages from induced  sputum33 but this is the first 
time it has been carried out in the equine species.
Table 1.  List of proteins related to immune response and lung biology derived from tracheal wash samples.
Protein ID Protein annotation
F7AUX9 Pulmonary surfactant-associated protein A OS = Equus caballus OX = 9796 GN = SFTPA1 PE = 4 SV = 1
F7DJE3 Surfactant protein D OS = Equus caballus OX = 9796 GN = SFTPD PE = 4 SV = 1
P01958 Haemoglobin subunit alpha OS = Equus caballus OX = 9796 GN = HBA PE = 1 SV = 2
F6QDH8 Alpha-amylase OS = Equus caballus OX = 9796 GN = LOC100051073 PE = 3 SV = 1
F7BAY6 Serum albumin OS = Equus caballus OX = 9796 GN = ALB PE = 4 SV = 1
F6V5H1 Immunoglobulin kappa constant OS = Equus caballus OX = 9796 GN = IGKC PE = 4 SV = 1
H9GZN9 Immunoglobulin heavy constant mu OS = Equus caballus OX = 9796 GN = IGHM PE = 4 SV = 1
F6SP74 Complement factor properdin OS = Equus caballus OX = 9796 GN = CFP PE = 4 SV = 1
Q9GKX7 Heat shock protein HSP 90-alpha OS = Equus caballus OX = 9796 GN = HSP90AA1 PE = 2 SV = 2
F6R6Z6 Epithelial cell adhesion molecule OS = Equus caballus OX = 9796 GN = EPCAM PE = 4 SV = 1
F6WA57 Lymphocyte cytosolic protein 1 OS = Equus caballus OX = 9796 GN = LCP1 PE = 4 SV = 1
F7CU94 Lysozyme OS = Equus caballus OX = 9796 GN = LYZ PE = 2 SV = 1
F7DBT2 Complement C1q C chain OS = Equus caballus OX = 9796 GN = C1QC PE = 4 SV = 1
F6VK89 CD14 molecule OS = Equus caballus OX = 9796 GN = CD14 PE = 4 SV = 1
F7CJ82 Arginase OS = Equus caballus OX = 9796 GN = ARG1 PE = 3 SV = 1
F7B5C4 Vimentin OS = Equus caballus OX = 9796 GN = VIM PE = 3 SV = 1
F6S981 MHC class II antigen OS = Equus caballus OX = 9796 GN = HLA-DRA PE = 2 SV = 1
F6QC83 Mucin 5AC, oligomeric mucus/gel-forming OS = Equus caballus OX = 9796 GN = MUC5AC PE = 4 SV = 1
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Proteomic analysis revealed a wide range of proteins in the equine TW samples, many of which have 
already been detected and reported in previously published studies on human and equine BALF and human 
 sputum32,34–36. Some of the detected proteins have previously been proposed as potential biomarkers for human 
lung cancer; these include carbonic anhydrase 1 (CA1), apolipoprotein A2 (APOA2), transthyretin (TTR), 
clusterin CLU, ceruloplasmin (CP) and gelsolin (GSN)35. In a similar context, TW proteomics can be envisioned 
in terms of biomarker screening for the development of ‘real’ biomarkers with potential future clinical utility in 
relation to two common respiratory diseases in horses; namely, equine asthma and exercise induced pulmonary 
 haemorrhage6,37. Moreover, results may have translational application to human respiratory disorders, such as 
equine asthma or respiratory infections.
Several proteins were related to important biological processes of the respiratory system, such as cellular 
function/differentiation [annexin (ANXA4, ANXA7), cathepsin B (CTSB), transgelin 2 (TAGLN2)], immune 
defense/response [CD14 molecule (CD14), lysozyme (LYZ), complement components (C1QB, C1QC, C3, C4A, 
CFB)] and antigen processing and presentation [MHC class II DR alpha chain (DRA), beta-2-microglobulin 
(B2M), heat shock proteins (HSPA1A, HSP90AB1)]. Interestingly, MUC5AC, also detected in our analyses, has 
previously been shown to be one of the predominant mucins in airway secretions derived from healthy horses and 
humans. Both MUC5AC and MUC5B are products of epithelial goblet cells and submucosal  glands38–40. Finally, 
consistent with the cytological profile of the TW samples derived from a Thoroughbred racehorse population 
and the high presence of haemosiderophages, several proteins related to haematopoietic homeostasis were also 
present in the equine TW samples; examples include haemoglobin, zeta (HBZ1) and glucose-6-phosphate dehy-
drogenase (G6PD). Even though there was no evidence of remarkable blood contamination within the samples, 
it is possible that some of these proteins may have originated from blood serum. This is a common problem, 
when performing proteomics from body  fluids41,42, and should therefore be taken into consideration, especially 
when analysis is applied on animals with airway inflammation.
The non-bronchoscopic method of collecting human BALF is well recognised in paediatrics, where a formal 
bronchoscopy is both technically challenging and difficult to justify without clear clinical need. As it is relatively 
less invasive, this alternative technique has several advantages over formal bronchoscopy in the paediatric set-
ting. Furthermore, it requires relatively minimal training, avoids the requirement for expensive equipment and 
is quick and well tolerated by both patients with and without chest infection. Its adoption is therefore suited to 
medical research in resource limited settings. Although previously used to successfully obtain dendritic cells 
from healthy children and those with RSV  bronchiolitis43, this is the first report of its use to obtain samples for 
proteomic analysis.
In conclusion, we have developed a robust protocol for obtaining a high quantity and quality of RNA and 
protein for transcriptomic and proteomic analysis from a single equine TW sample. Our “proof of principle” 
results should facilitate future gene-expression and extensive proteomic studies offering deep proteome coverage 
utilizing TW samples. These technological advances have the real capacity to improve our understanding of the 
function of the pulmonary immune system of the horse. They may also permit a more definitive and compre-
hensive characterization of common diseases such as equine asthma, potentially revealing not only disease sus-
ceptibility-associated biomarkers but also novel therapeutic targets. Finally, comparative global analysis of gene/
Figure 5.  Functional analysis of the equine tracheal wash proteome. Ingenuity Pathway Analysis software was 
used to determine the (a) most enriched canonical pathways and (b) diseases and biofunctions associated with 
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protein expression across airway derived samples between horse and human would allow further investigation of 
the horse as an appropriate candidate model for human disease, under the umbrella of the “One Health” concept.
Methods
Samples used in the study. Equine samples. Tracheal secretions were collected from 39 (38 male and 
1 female) Thoroughbred horses [7 ± 0.2 years (mean ± SEM); range 4–12 years]. All horses were housed at the 
same racing yard and samples were obtained as part of a routine assessment of respiratory health (differential 
cytology). Residual sample was retained for an ongoing proteomic and transcriptomic study. Sample collection 
procedures were approved by the Veterinary Ethical Review Committee of the School of Veterinary Medicine, 
University of Edinburgh, following the relevant guidelines and regulations relating to the provisions of the Ani-
mals (Scientific Procedures) Act 1986. All methods reported are in accordance with ARRIVE guidelines (https:// 
arriv eguid elines. org)44. Informed consent was obtained from the trainer for the use of residual sample material. 
Four BALF samples were collected at the Royal (Dick) School of Veterinary Studies, University of Edinburgh. All 
horses were clinically healthy and treated according to standard welfare procedures.
Murine samples. Bronchoalveolar lavage fluids were generously provided by Prof Jurgen Schwarze (Medical 
Research Council Centre for Inflammation Research, University of Edinburgh, UK). Samples were collected from 
four wild type BALB/c female mice, aged 8–12 weeks, at four days following intranasal administration of UV 
treated Respiratory syncytial Virus (RSV) as described by Kast et al.45. These mice represented controls to com-
pare against models of RSV infection for investigating the influence of RSV infection on tight junction integrity. 
All experimental procedures were carried out in accordance with ARRIVE guidelines (https:// arriv eguid elines. 
org)44,45. All experimental protocols were approved by the Ethical Review Committee of the Medical Research 
Council Centre for Inflammation Research, University of Edinburgh, UK, as previously  described45. All methods 
were carried out in accordance with relevant guidelines and regulations of the Home Office  regulations45.
Figure 6.  Pathway analysis identifies networks comprising immune-related proteins. Detected proteins are 
involved in “Cellular Function” and “Maintenance”, “Humoral Immune response” and “Inflammatory Response”. 
The network is displayed graphically as nodes (proteins) and edges (the biological relationships between nodes). 
Analysis was performed by the Ingenuity Pathway Analysis software (IPA Spring 2021 release, https:// www. qiage 
nbioi nform atics. com/ produ cts/ ingen uity- pathw ay- analy sis)30.
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Paediatric samples. Bronchoalveolar lavage fluid was collected from three children, with no evidence of lung 
disease, who were undergoing planned procedures under general anaesthetic. Children were attending for 
planned surgical procedures (inguinal hernia and hypospadias repair and developmental dysplasia of the hip 
repair) and were aged 6 months, 2 and 5 years old (2 female, 1 male). Children were sampled at the Royal Hos-
pital for Sick Children Edinburgh as part of the Lower respiratory tract infection Kids Study approved by the 
South East Scotland Research Ethics Committee 02. Informed consent was obtained from appropriate adult with 
parental responsibility. The clinical study and all associated procedures were conducted within Good Clinical 
Practice guidelines and the regulations stipulated by the MHRA (Medicines Healthcare Regulation Agency).
Sample collection. Equine samples. All TW samples were collected one hour following morning exercise 
(interval training) using a trans-endoscopic technique, as previously  described5. Horses were restrained and 
a nose twitch applied when necessary. A 1500 mm working length, 9.2 mm outer diameter video endoscope 
(2.8 mm biopsy channel; Aohua, China), was passed via the ventral nasal meatus to the pharynx and then ad-
vanced into the trachea via the rima glottidis. Following assessment of the amount and nature of mucus deposits 
within the tracheal lumen, approximately 20 ml of sterile 0.9% saline at room temperature was instilled via a 
catheter passed via the biopsy channel of the endoscope at the proximal aspect of the trachea. The endoscope 
was then further advanced to the level of the thoracic inlet where the pool of instilled fluid had gravitated. As 
much fluid as possible was subsequently aspirated via the transendoscopic catheter. Samples were stored on ice 
and submitted for laboratory analysis at the Roslin Institute and the Royal (Dick) School of Veterinary Studies 
and processed within 4–5 h of collection. Three BALF samples were collected at the Royal (Dick) School of Vet-
erinary studies from horses admitted to the hospital, as previously  described46; these procedures were performed 
for diagnostic purposes, with residual BALF made available for this study with owner consent.
Murine samples. Bronchoalveolar lavage fluid was collected by injecting 1 ml of PBS containing protease inhib-
itor via tracheal cannula—650–900 µl of fluid being retrieved, as previously  described45. BALF supernatant was 
then collected and stored at − 80 °C till further use.
Paediatric samples. The non bronchoscopic bronchoalveolar lavage protocol was adapted from the European 
Respiratory Society BAL guidelines for  children47, by the specialist paediatric physiotherapist Andrea Wood and 
Dr Jonathan Twynam-Perkins to allow less invasive and technically simpler sampling of the bronchoalveolar 
space in children. While anaesthetised a suction catheter was inserted blindly down the endotracheal tube and 
2 ml/kg of 0.9% sodium chloride instilled and around 1 ml/kg of fluid being retrieved. Following a short period 
of time, and without removing the suction catheter, sample was collected by applying 10-15kpa of suction to 
said catheter. Resultant BALF was spun at 400×g at 4 °C for 10 min, the supernatant collected and then frozen 
at − 80 °C for storage and further analysis.
Total and differential cell count and total cell and macrophage isolation for equine tracheal 
wash samples. Differential cell count. An aliquot of 0.5 ml was submitted to the pathology lab at the Royal 
(Dick) School of Veterinary Studies for DCC analysis. Differential leucocyte count (minimum of 200 cells) was 
performed and expressed as a percentage of total non-squamous and non-epithelial nucleated cells. An aliquot 
was retained for cytological analysis as described  previously23,48. Briefly, cell numbers were adjusted to 5 ×  105 
cells/ml by the addition of a calculated volume of PBS. From this aliquot, 2 cytospin slide preparations were 
made per lavage [cytospined at 300 rpm (10 g) for 3 min] and stained (Leishman stain; L/1815L/PB05, Fisher 
Scientific, Leicestershire, UK) and a differential cell count calculated under light microscopy by counting 200 
cells per animal.
Horses were considered free of inflammatory airway disorders based on the following DCC cut off values: 
neutrophils < 20%4,5.
Total cell isolation. First, a 1 ml aliquot of sample was immediately stored at − 80 °C for future proteomic analy-
ses and the remaining sample incubated for 15 min at room temperature in 0.1% dithiothreitol (DTT) to depo-
lymerize secreted mucin. Dithiothreitol has been demonstrated to cause no deleterious effects on human airway 
derived cells or interfere with surface marker measurements using flow  cytometry49. Following gravity filtration 
through a 70 µm pore mesh filter, the sample was centrifuged at 400×g for 10 min at 4 °C. Supernatant was care-
fully removed, and the cell pellet resuspended in Dubelcco’s PBS, from which a total cell count (excluding squa-
mous epithelial cells) and cell viability (Trypan Blue exclusion staining) was performed using a haemocytometer. 
Afterwards, the cell pellet was resuspended in 1 ml of Trizol and stored at − 80 °C for future RNA analysis.
Macrophage isolation. Following total cell isolation, immunomagnetic separation was used to isolate mac-
rophages from DTT treated TW samples from 16 of the 39 animals, using magnetic beads coated with mouse 
anti-human CD163 antibody (GHI/61, BioLegend, cat no 333605), according to the manufacturer’s instructions. 
We have previously demonstrated cross-reactivity of CD163 antibody with equine macrophages/monocytes23. 
Briefly, the cells were first stained with a R-Phycoerythrin (PE)-conjugated CD163 primary antibody; subse-
quently, the cells were magnetically labelled with anti-PE MicroBeads (Miltenyi Biotec, cat no 130-105-639) 
before the cell suspension was loaded on a  MACS® LS Column (Miltenyi Biotec Ltd., cat n0 130-042-401), placed 
in the magnetic field of a MACS Separator. The magnetically labeled cells were retained within the column, while 
the un-labeled cells passed through. Following removal of the column from the magnetic field, magnetically 
retained cells were eluted as the positively selected cell fraction.
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Flow cytometry analysis of tracheal wash derived cells. Total TW cells were stained with anti-
CD163 antibody against macrophages (BioLegend, Catalogue No. 333605). Cells were also stained with Zombie 
aqua dye (Biolegend, Catalogue No. 423101) to test for viability. A negative/isotype control was used to control 
for non-specific binding (PE Mouse IgG1, κ Isotype Ctrl, Biolegend, Catalogue No. 400111). Data were acquired 
on 10,000 live cell events and cells gated according to size (FSC-A: forward scatter) and granularity (SSC-A: side 
scatter) after removing artifacts, debris, doublet discrimination and dead cells. Data analysis was performed in 
 FlowJo® v10.5.3 (Tree Star, https:// www. flowjo. com/).
RNA analysis of equine tracheal wash derived cells. Total RNA extraction. Total RNA was ex-
tracted using a combination of Trizol reagent (Thermo Scientific™, 15596026) and an RNAeasy plus micro kit 
(Qiagen, cat no 74034), according to manufacturer’s instructions. Briefly, following removal of the superna-
tant, the remaining cell pellet was lysed by the addition of 1 ml Trizol Reagent. Subsequently, 0.2 ml 1-Bromo-
3-chloropropane (BCP) (Sigma Aldrich, cat no B9673-200ML) was added per 1 ml of Trizol. The sample was 
shaken vigorously for approximately 30 s and left at room temperature for 5 min to allow complete dissociation 
of nuclear-protein complexes. The homogenate was then centrifuged at 18,000×g for 15 min at 4 °C resulting in 
the formation of a lower red phenol–chloroform phase, an interphase, and an upper colourless aqueous phase. 
The aqueous phase contained the RNA and had almost 50% of the volume of the Trizol used, plus the volume 
of the sample. Following transfer to a clean tube for the precipitation step, 0.5 ml of 70% ethanol was added, the 
sample stored for 2 h at − 20 °C and then transferred to an RNeasy spin column and centrifuged at 18,000×g for 
5 min at 4 °C. Following centrifugation, the flow through was removed, the RNA washed once with RW1 buffer 
and DNA treatment was performed using the RNase-Free DNase Set (Qiagen, cat no 79254) according to the 
manufacturer’s instruction. Due to potential DNA contamination, this step was performed twice and samples 
were run through gDNA Eliminator Spin Columns twice after the elution step. Afterwards, the RNA membrane 
was washed with RW1, RPE and 80% ethanol. Finally, RNA was eluted in 20 µl RNase-free water and RNA sam-
ples were stored at − 80 °C until further use.
RNA quality assessment. RNA concentration and purity were measured using ND-1000 Nanodrop spectro-
photometer (Thermo Scientific, Wilmington, USA) by measuring absorbance at 260 and 280 nm (A260, and 
A280 respectively). Purity of RNA was determined using the A260/A280 ratio. A ratio close to two was con-
sidered to be indicative of pure RNA. RNA integrity was confirmed with the High Sensitivity RNA ScreenTape 
system (Agilent Technologies). A RIN number greater than seven was considered appropriate for RT-qPCR and 
RNAseq analysis.
Protein analysis. Briefly, an aliquot of 500 µl of untreated TW or BALF samples was homogenized in pro-
tein extraction buffer (100 mM Tris, pH 7.6 and 4%w/v SDS) + 1% Halt Protease Inhibitor Cocktail, EDTA-Free 
(Thermo Scientific, cat no 87785). Following homogenization, samples were centrifuged at 20,000×g for 20 min 
at 10 °C. The supernatant containing the solubilized protein was removed and stored at − 80 °C. Protein con-
centration of samples was determined using a Micro BCA Protein Assay Kit (Thermo Scientific™, cat no 23235) 
according to the manufacturer’s instructions. Finally, total protein analysis was carried out for quality control 
purposes and to determine equivocal protein load between samples. Samples were separated by electrophoresis 
on gradient gels (NuPAGE 4–12% Bis–Tris Protein Gels, 1.0 mm, 12-well, Fisher Scientific, cat no NP0322BOX) 
and stained with InstantBlue™ Protein Stain (Expedeon Ltd, cat no ISB1L) as previously  described50. The stained 
gel was then imaged using the LICOR Odyssey imager to visualise and quantify the total protein load within 
each lane of the gel using the associated Image Studio Software (https:// www. licor. com/ bio/ odyss ey- fc/, https:// 
www. licor. com/ bio/ image- studio- lite/, Version 5.2).
Trachea wash sample preparation for LC–MS. Sample preparation for LC–MS was carried out using S-Trap 
micro spin column digestion protocol (Protifi, Huntington, NY). Samples containing 5–10 μg of protein, were 
diluted to 50 μL with lysis buffer (5% SDS in 50-mM TEAB) and reduced with 20 mM Dithiothreitol at 95 °C 
for 10 min. After cooling to room temperature, samples were alkylated in the dark for 30 min with 40 mM of 
iodoacetamide. This mix was then acidified to 1% phosphoric acid and proteins were precipitated with 350 μl 
of binding buffer [90% methanol, 100-mM Triethyl ammonium bicarbonate (TEAB)]. This protein suspension 
was loaded onto S-Trap column columns and centrifuged at 4000×g for 30 s. After four washes with 125 μl of 
50-mM TEAB, trypsin (0.5 μg in 50 mM TEAB) was added to the trap and incubated overnight. Peptides were 
then eluted with 80 μl of each of the following: 50-mM TEAB, 0.2% formic acid (FA), and 50% acetonitrile in 
0.2% FA with centrifugation at 1000 g after each elution step. All elution fractions were pooled and dried under 
vacuum and cleaned up by stage-tipping51.
LC–MS analysis on tracheal wash samples. Nanoflow LC–MS/MS was performed on a micrOTOF-II mass 
spectrometer (Bruker, Germany)52 coupled to a RSLCnano LC system (Thermo) following earlier  method53 with 
minor modifications. Raw spectral data were processed with DataAnalysis (Bruker) software and the resulting 
peak lists were searched using Mascot 2.4 server (Matrix Science) against Uniprot horse sequence database 
(Uniprot ID UP000002281), containing 44,485  entries52. Precursor and fragment ion mass tolerance were set at 
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Protein function annotation and pathway analysis. As previously  described54, identification of 
enriched KEGG pathways and biological processes in the protein list was performed with Database for Annota-
tion, Visualization and Integrated Discovery (DAVID) software (v6.8)29,55,56. KEGG pathway database contains 
regulatory and metabolic pathways, representing global knowledge on molecular interactions and reaction net-
works. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA Spring 2021 release, https:// 
www. qiage nbioi nform atics. com/ produ cts/ ingen uity- pathw ay- analy sis)30 to infer the functional roles and rela-
tionships of the detected proteins.
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